Home » GSK Muscular Dystrophy Drug Gets Breakthrough Status
GSK Muscular Dystrophy Drug Gets Breakthrough Status
The FDA has granted GlaxoSmithKline breakthrough status for its Duchenne muscular dystrophy drug drisapersen.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May